BioCentury
ARTICLE | Company News

Advanced Cancer Therapeutics, University of Louisville deal

June 8, 2009 7:00 AM UTC

Advanced Cancer received exclusive, worldwide rights from the university's James Graham Brown Cancer Center to develop and commercialize CK37. The small molecule inhibitor of choline kinase (CHK) is...